Janney Montgomery Scott LLC Buys 588,124 Shares of iShares Biotechnology ETF $IBB

Janney Montgomery Scott LLC increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1,871.5% in the 4th quarter, Holdings Channel reports. The firm owned 619,550 shares of the financial services provider’s stock after purchasing an additional 588,124 shares during the period. Janney Montgomery Scott LLC’s holdings in iShares Biotechnology ETF were worth $104,562,000 as of its most recent filing with the SEC.

A number of other large investors have also recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets lifted its stake in shares of iShares Biotechnology ETF by 11.4% in the fourth quarter. BNP Paribas Financial Markets now owns 2,133,461 shares of the financial services provider’s stock worth $360,064,000 after buying an additional 218,066 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of iShares Biotechnology ETF by 27.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock worth $153,039,000 after buying an additional 226,852 shares during the period. LPL Financial LLC grew its stake in iShares Biotechnology ETF by 145.9% in the 4th quarter. LPL Financial LLC now owns 992,799 shares of the financial services provider’s stock valued at $167,555,000 after buying an additional 589,033 shares during the last quarter. Truist Financial Corp raised its holdings in iShares Biotechnology ETF by 2,239.6% in the 4th quarter. Truist Financial Corp now owns 642,023 shares of the financial services provider’s stock worth $108,354,000 after acquiring an additional 614,582 shares during the period. Finally, WestEnd Advisors LLC bought a new position in iShares Biotechnology ETF in the 4th quarter worth $106,276,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $165.93 on Thursday. iShares Biotechnology ETF has a fifty-two week low of $123.61 and a fifty-two week high of $179.64. The firm has a fifty day moving average price of $170.24 and a two-hundred day moving average price of $170.63.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were given a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.